Natera, Inc. (NASDAQ:NTRA) headquartered in San Carlos, will host a conference call for the investment community to discuss the 3Q20 earnings result on 5th November 2020 at 4:30 PM Eastern Time.
Those interested in listening to the conference call live via the Internet can visit www.natera.com
Earnings Expectation
Natera, Inc. is expected to report third quarter earnings results, after market close, on Thursday 5th November 2020. Analysts polled by Thomson Reuters anticipate third quarter loss of $ 0.68 per share from revenue of $ 87.24 million. Looking ahead, the full year loss are expected at $ 2.55 per share on the revenues of $ 359.49 million.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 345.00 million ~ $ 365.00 million
Click Here For More Historical Outlooks Of Natera, Inc.
Natera, Inc., a diagnostics company, provides preconception and prenatal genetic testing services. It primarily offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases that could be passed on to the carriers children; and Spectrum pre-implantation genetic screening and Spectrum pre-implantation genetic diagnosis to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle. The company also provides Anora products of conception test to analyze fetal chromosomes to understand the cause of miscarriage; and non-invasive paternity testing products to determine paternity by analyzing the fragments of fetal deoxyribonucleic acid in a pregnant mothers blood and a blood sample from the alleged father.
